Trial · NCT01233869
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Initial Treatment Period (24 Months) | STARTED | Bosutinib 200 mg/Day | 58 | |
| Initial Treatment Period (24 Months) | STARTED | Bosutinib 400 mg/Day | 31 | |
| Initial Treatment Period (24 Months) | STARTED | Bosutinib 400/200 mg/Day | 24 | |
| Initial Treatment Period (24 Months) | STARTED | Placebo | 56 | |
| Initial Treatment Period (24 Months) | COMPLETED | Bosutinib 200 mg/Day | 34 | |
| Initial Treatment Period (24 Months) | COMPLETED | Bosutinib 400 mg/Day | 3 | |
| Initial Treatment Period (24 Months) | COMPLETED | Bosutinib 400/200 mg/Day | 22 | |
| Initial Treatment Period (24 Months) | COMPLETED | Placebo | 34 | |
| Initial Treatment Period (24 Months) | NOT COMPLETED | Bosutinib 200 mg/Day | 24 | |
| Initial Treatment Period (24 Months) | NOT COMPLETED | Bosutinib 400 mg/Day | 28 | |
| Initial Treatment Period (24 Months) | NOT COMPLETED | Bosutinib 400/200 mg/Day | 2 | |
| Initial Treatment Period (24 Months) | NOT COMPLETED | Placebo | 22 | |
| Washout Period 30 Days | STARTED | Bosutinib 200 mg/Day | 34 | |
| Washout Period 30 Days | STARTED | Bosutinib 400 mg/Day | 3 | |
| Washout Period 30 Days | STARTED | Bosutinib 400/200 mg/Day | 22 | |
| Washout Period 30 Days | STARTED | Placebo | 34 | |
| Washout Period 30 Days | COMPLETED | Bosutinib 200 mg/Day | 34 | |
| Washout Period 30 Days | COMPLETED | Bosutinib 400 mg/Day | 3 | |
| Washout Period 30 Days | COMPLETED | Bosutinib 400/200 mg/Day | 22 | |
| Washout Period 30 Days | COMPLETED | Placebo | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01233869/flow